The March of Dimes Innovation Fund’s purpose is to invest in innovations that focus on key drivers of maternal and infant health outcomes, such as:
- Prevention of spontaneous preterm birth, birth defects and other adverse newborn outcomes.
- Support after adverse perinatal outcomes.
- Reduce adverse outcomes driven by non-medically indicated inductions and Cesareans.
- Reduce adverse pregnancy outcomes due to cardiovascular disease.
- Improve support for chronic maternal stress and maternal mental health conditions.
Investments to date
Raydiant Oximetry is a venture-backed, clinical-stage company dedicated to improving outcomes for mothers and babies during childbirth. The company was founded by Neil P. Ray, MD, a pediatric anesthesiologist, to find a solution to the pervasive problem of identifying fetal distress and potentially avoiding medically unnecessary C-sections, which can have short- and long-term implications for the mother and child
Iron Health empowers OBGYNs to improve patient outcomes by extending their latitude of care. Iron Health complements standard OBGYN care by bridge gaps across the health journey by supporting their patients with convenient and comprehensive care, from primary care and behavioral health to weight management and pregnancy support.
If you're an early-stage company seeking funding, please submit this initial application form here.
If you're interested in learning more about our Innovation Fund, please reach out to Eric Schaefer at [email protected]
If you're interested in making a philanthropic contribution to our Innovation Fund, please reach out to Karyn DeMartini at [email protected]